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We have used in situ hybridization to investigate the expression of TNF-c genes by
thymic cells during fetal development in mice. In 14-day-old fetal thymuses, very scarce
cells produce TNF- mRNA. A second phase of cytokine gene expression starts on day
16. The density of positive cells progressively increases up to day 20. Thymuses at 15
days of gestation and after birth do not express detectable cytokine mRNA. In an
attempt to identify the nature of the TNF-c mRNA-producing cells, acid phosphatase
activity, which is characteristic of the macrophage lineage, was studied in the same
thymuses. Acid phosphatase-positive cells only appear on day 15. Their frequency
increases up to birth. However, no correlation can be established between acid
phosphatase--and TNFo mRNA--positive cells. The results indicate that a small subset
of thymic cells is responsible for TNF-cmRNA production during ontogeny: These cells
are not yet identified. The possible role of TNF-o in thymic ontogeny is discussed.
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INTRODUCTION
A central issue of T-cll ontogeny is the identifi-
cation of the signals and growth factors required
for the proliferation and differentiation of imma-
ture cells in the thymus. TNF- may be one of
these signals. This protein was initially described
as cytostatic and cytotoxic against a variety of
tumor cells (Carswell et al., 1975) and normal cell
types (Broxmeyer et al., 1986). Besides, TNF-o
can induce a number of negative and positive
regulators of cell growth [e.g., granulocyte-mac-
rophage CSF (Munker et al., 1986), IL-1 (Nawroth
et al., 1986), IFN-fl2 (Kohase et al., 1986)] in a
variety of .cell types. These latter observations
suggest that TNF-o may also be involved in the
control of cell proliferation and differentiation.
Several experimental data suggest that TNF-o
may play a role in thymic lymphopoiesis. It
stimulates thymocyte proliferation in vitro in
association with other cytokines: It synergizes
with IL-2 and IL-7 on the CD4-CD8- double-
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negative subset of adult thymocytes (Suda et al.,
1990b) and with IL-2 on day-15 murine fetal thy-
mocytes (Suda et al., 1990a). It induces the pro-
duction of IL-6 by fetal thymocytes (Ranges et al.,
1988) and the expression of IL-2 receptors on
their cell .membrane (Lowenthal et al., 1989).
Moreover, TNF-o stimulates the capacity of some
thymic epithelial cells to establish interactions
with immature thymocytes (Defresne et al.,
1990).
The mechanisms by which TNF-o exerts its
activities are still unknown, as well as the nature,
frequency, and ontogeny of the producing cells
in the thymus. All the data available on its pro-
duction come from in vitro studies with thymo-
cytes stimulated by PHA (Ranges et al., 1988),
PMA and calcium ionophore (Suda et al., 1990a),
or ConA and TPA (Reem et al., 1989). These in
vitro data do not yield data on the events inside
the intact organ. Therefore, we opted for using in
situ RNA-RNA hybridization on thymus frozen
sections to study the presence of cells expressing
TNF-o transcripts in the developing thymus. In
an attempt to characterize the thymic-producing
cells, we have simultaneously identified the pres-
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ence of acid phosphatase, an enzyme character-
istic for monocytes and macrophages (Duijvestijn
et al., 1983), which are known to produce TNF-z
in many organs (Matthews, 1981).
Our observations clearly demonstrate two
waves of TNF-z mRNA production during thy-
mic ontogeny: The first one occurs at day-14 of
gestation; the second one starts at day 16 and
reaches its highest level around birth. The nature
of the cells responsible for these two waves is not
yet identified. Because only a small fraction of
thymic cells is expresging TNF-cz, even at the
peak level of production at day 20, and because
they are located in the thymic cortex, it could be
suggested that thymic nonlymphoid cells (e.g.,
nurse cells) participate in this production.
(a) (b)
(c) (d)
FIGURE 1. Detection by in stu hybridization of TNF-o mRNA in fetal thymus frozen sections. Cells containing TNF-o mRNA
are identified by the presence of clusters of dark grains (A), they are located in the cortex, C, at day 20 of gestation (B).
No hybridization is seen with the control sense probe for TNF-o (C) or after pretreatment of the sections with RNAse (D).
(A, C: x5400: B,D: x1350).TNF-a mRNA IN THE MURINE THYMUS 105
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FIGURE 2. Frequency of thymic
cells producing TNF-c mRNA
during ontogeny as assessed by
RNA-RNA .in situ hybridization:
The total number of positive cells
was counted on the totality of each
section using a light microscope
(Leitz) and the section area was
estimated with an image analyzer
(IBAS).
RESULTS
Production of TNF-a mRNA in the Thymus
During Ontogeny
As shown in Fig. 1, cells that produce TNF-o
mRNA were detected on frozen sections of fetal
thymuses (Fig. 1A). T’hese cells were located in
the outer part of the thymic lobes and in the cor-
tex at day 20 of gestation when the cortex and the
medulla were clearly segregated (Fig. 1B).
There was a striking age-dependent distri-
bution of TNF-o mRNA-producing cells (Fig. 2).
Within 14-day thymuses, a significant number of
cells contained TNF-o mRNA. A second phase of
cytokine production started in 16-day thymuses:
the density of positive cells increased progress-
ively up to 20 days of gestation. In between these
two waves of lymphokine production, 15-day
fetal thymic cells did not express any detectable
TNF-o mRNA. Similarly, the density of cells
showing TNF-b gene expression decreased
immediately after birth.
The specificity of hybridization was assessed
using a TNF-c probe of the sense orientation (i.e.,
the same polarity as cellular RNA) or by pretreat-
ing the sections with RNAe. Under such control
conditions, no detectable hybridization signals
were seen (Figs 1C and 1D). This chronology of
TNF-o mRNA production in the fetal thymus
was reproduced in five independent
experiments.
Acid Phosphatase Activity in the Thymus
During Ontogeny
Because cells of the histiocytic lineage are the
most frequent TNF-c producers in a variety of
tissues or organs (Matthews, 1981), we identified
macrophages in fetal thymuses by histoenzym-
ology (Duijvestijn et al., 1983).
Acid phosphatase-positive cells were not
observed within 14-day fetal thymuses (Fig. 3A
and 4). The first positive cells appeared at day 15
and their frequency progressively increased to
reach a maximum between the day 20 of ges-
tation and the fifth day after birth. These cells
were located both in the cortex and in the med-
ulla (Fig. 3B).
DISCUSSION
In this work, we explored the TNF-o mRNA-pro-
ducing capacity of fetal thymuses. We detected
two waves of cytokine production: The first one
occurs on day 14 of gestation, and the second one106 J. DEMAN et al.
(a) (b)
FIGURE 3. Detection of acid phosphatase-positive cells in fetal thymus frozen sections: They are identified by the presence of
granulations within their cytoplasm. No positive cells are observed within 14-day thymuses (A) (x2160). They appear at day 15
and their frequency increases progressively up to day 20 (B) (x540): they are located in the cortex, C, and in the medulla, M.
peaks on day 20. rFhe specificity of the reaction
was assessed by using TNF-o probe of the sense
orientation or by pretreating the sections with
RNAse. The low density of cytokine mRNA-pro-
ducing cells may explain why it has not been
possible to detect constitutive TNF-omRNA pro-
duction in fetal thymuses with conventional
Northern blot analysis (data not shown).
In an attempt to identify the cells responsible
for this TNF-o production, we looked for acid
phosphatase activity, which is a good marker of
thymic macrophages (Duijvestijn et al., 1983).
Acid phosphatase-positive cells are not observed
in 14-day thymuses. This suggests that cells pro-
ducing TNF-omRNA at this age of fetal develop-
ment do not belong to the histiocyte lineage.
They might be immature thymocytes: 14-day thy-
muses are indeed essentially composed by epi-
thelial cells and immature CD4-CD8- double-
negative thymocytes (Fwlkes and Pardoll, 1989),
which can be induced in vitro to produce TNF-o
(Suda et al., 1990a). Later on, the frequency of
acid phosphatase-positive cells increases up to
birth. The highest frequency of TNF-o mRNA-
expressing cells and the highest levels of acid
phosphatase activity are almost simultaneous in
20-day thymuses. However, it appears that only
cortical cells express TNF-o mRNA because the
hybridization signal is only observed within the
cortex, whereas acid phosphatase-positive cells
are located on the whole thymic section. It is thus
not clear that there exists a subpopulation of thy-
mic macrophages capable of producing TNF-o
together with thymocytes, however, it can be
suggested that other stromal cells (e.g., nurse
cells) participate in this production.
These observations suggest that TNF-o mRNA
production by thymic cells is controlled during
the ontogeny: These cells may thus be receptive
to the inductive signals required for cytokine
production only at distinct stages of their devel-
opment in vivo. This is in agreement with recent
observations (Carding et al., 1989) that the ability
of fetal thymocytes to produce IL-2 and IL-4TNF-o mRNA IN THE MURINE THYMUS 107
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FIGURE 4. Frequency of acid phosphatase-positive cells in the thymus during ontogeny assessed by histoenzymology. The total
number of positive cells and the section area are estimated with an iamge analyzer (IBAS).
mRNA as well as IL-2-receptor mRNA appears to
be dependent upon the developmental stage of
thymocytes.
The signals inducing TNF-o gene expression
within the thymus are presently unknown. In
vitro studies have shown that CD4-CD8- double-
negative adult thymocytes produce TNF-c after
stimulation with PMA and calcium ionophore
(Suda et al., 1990b). Similarly, human thymocytes
treated by PHA produce TNF-o (Ranges et al.,
1988) and when stimulated by ConA and TPA,
they express TNF-o mRNA (Reem et al., 1989).
The physiological equivalents of these activating
agents are unknown. It has been shown that IL-1,
IL-2, or IL-4 can modulate this production
(Ranges et al., 1988); moreover, the peaks of IL-2
and IL-4 mRNA expression in the fetal thymus
immediately precede the waves of TNF-c pro-
duction (Carding et al., 1989). This suggests that
these cytokines produced.in vivo and probably
acting in synergy may be required to induce the
TNF- secretion.
This cytokine may be crucial for the prolifer-
ation of fetal thymocytes. Whereas it is unable by
itself to stimulate the proliferation of thymocytes
in vitro (Suda et al., 1990b), it enhances the pro-
liferation induced by IL-2 or by IL-7 (Suda et al.,
1990b). Moreover, it stimulates thymocytes to
produce IL-6 (Ranges et al., 1988), another
growth factor that may be required for T-cell
development. Finally, in view of our recent
observations that TNF-o enhances the capacity of
epithelial cells isolated from thymic nurse cells to
establish interactions with immature fetal thymo-
cytes (Defresne et al., 1990), it is possible that this
cytokine provides the signals for the expression
in some thymic stromal cells of molecules facili-
tating the cell to cell contacts required for the
intrathymic selection processes (Marrack et al.,
1988).
MATERIALS AND METHODS
Mice
C57BL/Ka mice originating from Stanford Uni-108 J. DEMAN et al.
versity were raised in our animal colony. Fetuses
were obtained from timed matings; males and
females were accoupled for I night; the day when
they were separated was designated as day 1.
Tissue Preparations
Cryosections of thymuses (5 to 6/m) prepared at
-20C were placed on glass slides coated with
0.1 mg/mL of poly-c-lysine (Sigma). For in situ
hybridization, the sections were fixed in parafor-
ma.ldehyde (4% in PBS) containing 20mM vana-
dyl ribonucleosides complexes (VRC, Sigma) and
5 mM MgC12 for 15 min at room temperature.
After washing, sections were treated with 0.25%
Triton X-100 (Sigma) in PBS containing 20mM
VRC and 5 mM MgCI2 for 10 min at. room tem-
perature, dehydrated, and stored at 4C in 70%
ethanol. For acid-phosphatase detection, sections
were fixed in cold acetone (4 C) for 10 min and
stored a few days in a dessicator at room tem-
perature, or longer at-20 C.
Preparation of TNF-o probe
The PstI-PstI fragment from the cDNA clone
pGEM-lmTNF contains all of the coding
sequences for murine TNF-o. This vector was
kindly provided by Professor W. Fiers (Gent Uni-
versity, Belgium). Linearized plasmids were used
as templates for the in vitro synthesis of RNA
probes complementary to the cellular TNF-o
mRNA (antisense probe). RNA was also tran-
scribed from the opposite direction (sense probe)
and used as a negative control. These probes
were labeled by random priming using SP6 or T7
RNA polymerases and 3SS-labeled UTP according
to the supplier’s recommendations (Boehringer
Mannheim, Mannheim, FRG). Approximately lx
108 cpm were incorporated into RNA per/g of
RNA template.
In Situ Hybridization
Fifty microliters of probe mixture [50 tL of 50%
formamide containing NaC1 (0.6 M), Tris-HC1
(10 mM), EDTA (1 mM), 1% SDS, DDT (10 mM),
yeast t-RNA (0.25 mg/mL) (Boehringer Mannh-
ein, Mannheim, FRG), lx Denhardt’s (50x
Denhardt’s=1% Ficoll, 1% polyvinylpyrrolidine,
1% BSA), 10% PEG-6000 (polyethylene glycol-
6000) and 1/L of labeled RNA (150.000cpm/
/L)] was loaded on each slide and hybridization
was performed at 50C overnight in a humid
chamber. As a negative control, a few slides were
pretreated for 2 hr at 37C in a solution contain-
ing 20/g/mL of RNAse to destroy the mRNA or
the antisense probe was replaced by the sense
probe. Slides were then washed twice for 5 min
with PBSM (PBS containing 5 mM MgCI2), rinsed
30min in a solution containing 20flg/mL of
RNAse (Boehringer Mannheim, Mannheim, FRG)
in 0.5M NaC1 and 10mM Tris-HC1 (pH 8) at
37 C, then 30 min in the same solution except
RNAse at 37 C, 30 min with 50% formamide/2x
SSC (2xSSC=0.3M NaC1/0.03M sodium citrate)
at 50 C, and 30min in 50% formamide/lxSSC
containing 0.05% of Triton-X at 37 C. The slides
were then dehydrated successively in 30%, 50%,
and 70% ethanol in 300mM ammonium acetate
(pH 7.0), air dried, and finally autoradiographed.
Ilford K2 emulsion was diluted with an equal
volume of 300mM ammonium acetate. The slides
were dipped into the emulsion and allowed to
solidify horizontally at room temp.erature for
4 hr. The emulsion-coated slides were kept at
4C for 3-5 days for exposure. They were devel-
oped in Kodak D-19 developer (Eastman Kodak,
Rochester, NY) for 3 min. After a rinse in a 1%
acetic acid solution, the fixation was carried out
in an Ilford rapid fixer for 6 min and the slides
were washed twice with water for 30 min. They
were stained with hematoxilin-eosin for 2 min,
washed twice with water, and air dried. We con-
sidered as positive cells (cells expressing TNF-o
mRNA) those cells that had >8 grains per cell.
Acid Phosphatases Detection
The substrate used to detect acid phosphatases
was the naphtol As-Bi phosphate (Sigma N-
2250). The enzymatic reaction was performed as
follows: The substrate (60 mg) was dissolved in
acetone (3 mL) and 1,2-propyleneglycol (2 mL)
and added simultaneously with the coloring Fast
Garnet (60 mg) in 60 mL of an acetate buffer (pH
5.0; glacial acetic acid 1 M and sodium acetate
1M). Fast Garnet is a diazonium salt that
coupled and colored the naphtol complexes
hydrolyzed by acid phosphatases. The slides
were incubated for 30min at 37C in this
solution, rinsed with distilled water, and
counterstained with hematoxilin for 2 min. Acid
phosphatases are lysosomial enzymes and theTNF-a mRNA IN THE MURINE THYMUS 109
enzymatic activity in the cells appears as red
granulations within the cytoplasm.
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